31 March 2026 -- Zizers, Switzerland -- Scientists at Purdue University are using the WELLJET dispenser stacker from INTEGRA Biosciences to increase the speed, consistency and scale of drug screening for rare and neglected parasitic diseases. Integrating automated liquid handling into their workflows has allowed the research team to standardize complex screening assays, improve reproducibility and significantly increase throughput.

31 March 2026 -- Cambridge, UK -- Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).

24 March 2026 -- Cambridge, UK -- Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform.

19 March 2026 -- Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced a distribution agreement with PrimeTech Co., Ltd., a leading distributor of life science technologies in Japan. The partnership will bring Epigenica’s EpiFinder technologies to researchers and laboratories across the Japanese market.

19 March 2026 -- California, US -- Biotium, a leading provider of fluorescent reagents and kits for life science research, announces the release of the ViaPlex 2-Color Cell Barcoding Kit. Combining fluorescent staining with two reactive dyes, the ViaPlex kit allows researchers to label and combine up to 15 distinct cell populations for multiplex analysis in a single tube, reducing reagent consumption and sample running time without compromising data quality.

17 March 2026 -- Raubling, Germany -- Axplora today announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli. The latest phase includes construction of a new 4,500 m², three-storey R&D and laboratory hub, designed to accelerate development, expand execution capacity and deliver cost-efficient high-potency manufacturing at scale.

17 March 2026 -- Paris, France -- DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co., expanding global access to the Company’s SYNTAX? platform for decentralized, in-house and on-demand oligonucleotide production.

11 March 2026 -- California, US -- iXCells Biotechnologies USA, a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem cell (iPSC) lines as part of a multi-year collaboration with a global biotechnology company.

4 March 2026 -- Halle (Saale), Germany -- With the SONOFLOW CO.55 SD V3.0 flow meter, SONOTEC presents precision, process control, and uniqueness at the premiere of the Single-Use Event Basel on March 19, 2026, in Basel, Switzerland. Just one week later, bioprocess engineers will have the opportunity to experience the unique sensor family at GMP PharmaTechnica from March 24 to 25, 2026, in Wiesbaden, Germany.

24 February 2026 -- California, US -- Illumina today announced the launch of TruPath Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been found to deliver unparalleled accuracy and resolution—even across so-called “dark regions” of the genome—providing researchers with a more complete picture of genomic alterations implicated in genetic disease.

24 February 2026 -- London, UK -- PMGroup Worldwide Ltd are pleased to announce the acquisition of Laboratory News magazine and website, together with Laboratory Talk website, from Synthesis Media.

23 February 2026 -- Illinois, US -- AbbVie today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus.